REGENXBIO, Inc. (RGNX)

9.24 +0.20 (+2.21%) USD  |  NASDAQ  |  Mar 02, 16:00
9.58 +0.34 (+3.68%) After-Hours: 07:49
More

REGENXBIO Quarterly Revenue Estimates

Quarterly Revenue Estimates Chart

View Quarterly Revenue Estimates for RGNX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Revenue Estimates Range, Past 5 Years

View Quarterly Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Revenue Estimates Benchmarks

View Quarterly Revenue Estimates Benchmarks
Start Trial
Sarepta Therapeutics, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade
Omeros Corp. Upgrade
Ultragenyx Pharmaceutical, Inc. Upgrade
CytomX Therapeutics, Inc. Upgrade